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Medications Use and Patient Outcomes at Two Indianapolis
Area Skilled Nursing Facilities: a Retrospective Chart Review
Christine Brockett PharmD Candidate, Dr. Priscilla Ryder, MPH PhD
Background: Residential health care has changed over time. Skilled nursing
facilities (SNF) as an alternative to standard long-term care are understudied.
Objective: To describe current prescribing patterns of medication use in two
Indianapolis SNFs.
Method: Chart review to examine associations between medication use and
outcomes such as weight changes, falls and re-hospitalization. Discharged
patients had to be residents for at least 14 days.
Results: 35 charts were reviewed. 17 (48.6%) patients were male, 22 (62.9%)
were Caucasian, 15 (42.9%) had Medicaid, 6 subjects (17%) visited the
emergency department, 5 (14.3%) visited the hospital during their stay at the
selected facilities, 14 (40%) suffered falls, 23 (65.7%) took antidepressants, 15
(42.9%) received antibiotics and 4 (11.4%) had high anticholinergic burden.
Duration of stay ranged from 14-362 days (median 41), age ranged from 40-95
(median 75), number of diagnoses 4-23, mean 12 (±4.105), weight change from
loss of 52# to gain of 35.7# (median -5.6), Beer’s violations 0-3, mean 0.46
(±0.761) for patients aged ≥65 and the maximum scheduled medications at one
time 3-24, mean 9.26 (±4.273). Of the 15 (42.9%) patients that received
antibiotics there were 24 instances of use, 19 (79.2%) of those fit the facilities
criteria for appropriate use of antibiotics.
Conclusion: There are few associations between exposures: use of antibiotics or
antidepressants, anticholinergic burden, or deviations from Beer’s criteria. This
may be due to small sample size or be an indication of careful prescribing at
these facilities.
also residents in rehabilitation programs
Introduction
and under disability in these facilities.
The geriatric population is at a large
There are many specific points of
risk of problems from medications. The first
medication use that could be studied for
risk is polypharmacy; as age decreases and
any variety of reasons leading to interesting
health declines the medication burden for
discoveries that may eventually guide and
1
the geriatric population also increases. The
alter prescribing practices in the future. One
majority of residents at skilled care nursing
concerning point of medication use is the
facilities (SNUs) are geriatrics, therefore
potential overuse of antibiotics. Up to 50that was the population targeted in this
75% of long-term care residents use
study. Not all residents studied were of the
antibiotics in a single year and 22-89% of
geriatric population though, since there are
those uses may be deemed to be
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unwarranted.2, 3 Potential concerns with
this excessive use include microbial
development of drug resistance, adverse
events from the medications, drug
interactions and increased cost to the
resident.2 To prevent these problems, there
is a recommendation for antibiotic
protocols to be in place to assist in
determining whether an antibiotic should
be used or not.2, 3 There are many studies
available to recommend protocols including
a study by Leob et al in 2001.2,3
Another concern in prescribing
practices is the diagnosis and treatment of
depression. Teresi et al performed a study
in 2001 that found 5-31% of residents in
long-term care displayed symptoms of
depression and only 15-27% of that
population received treatment for
depression symptoms.4 An added concern is
that the early symptoms of dementia
frequently overlap with depression
symptoms and can complicate diagnosis,
necessitating treatment and monitoring by
a psychiatric specialist.4
Another potential study point is the
concerning anticholinergic side effects of
many medications currently on the market.
The geriatric population is not only at an
increased risk due to polypharmacy, but
also because of an increased sensitivity to
anticholinergic effects with age.5-7 20-60%
of geriatric patients have anticholinergic
exposure with at least 1 prescribed
medication.5, 8 The potential anticholinergic
problems include incontinence and
cognitive impairment that may cause such
consequences as falls, fractures, and
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wounds resulting in infections, or vehicular
accidents.5, 7 The consequences of
anticholinergic drug effects have stimulated
many studies into determining the
anticholinergic effect that various
medications can have in the body and there
are now several ways in which to measure
that.5 Serum radioreceptor anticholinergic
activity assay (SAA) is a laboratory test that
can be used on medications but has been
shown to have no direct association to
anticholinergic reactions in patients.5 Drug
affinity to muscarinic receptors can be
tested in vivo, but application of results is
only reflected in peripheral effects, not the
cognitive effects of the medications
because it does not put into consideration
the blood-brain barrier (BBB) which
protects the nervous system.5 Expert-based
drug lists are the most clinically relevant
method as it uses a list compiled by experts
based on what has been seen to cause
anticholinergic effects in practice.5 At least
3 different drug lists have been published in
journals for anticholinergics by August of
2011 based on an EBSCO database search.
The anticholinergic drug scale (ADS) was
based entirely on SAA reports and is
therefore not truly ‘expert-based’ and is
suspect in strength of findings due to the
doubt that is placed in results from the
SAA.5, 7, 8 The Anticholinergic risk scale (ARS)
takes into account both peripheral and
central effects of anticholinergic side effects
but no literature review was performed in
its development, weakening the evidence
behind its use.5 The anticholinergic
cognitive burden scale (ACB) was developed
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by Boustani, Campbell et al in 2008 and did
use both a clinical study with expert
assistance and a literature review in
development of their scale.5
With the general sensitivity to
medications of the geriatric population,
there have been several different
prescribing criteria for use in geriatrics to
minimize complications. Side effects of
concern include confusion, constipation,
depression, and falls leading to broken
bones and immobilization.9 The two most
commonly used are Beers criteria and the
Canadian criteria.9 Beers criteria, which is
the list used in most of the USA, was
originally written in 1991 and has been
updated several times including in 2003
then again in 2011 after this study was
initiated.

Methods
Population
Skilled nursing facilities in the
Indianapolis area were selected as the site
of the study due to heavy geriatric
population, researcher connections with
the facilities and variety of residents from
long-term care to rehab patients. Patients
were required to have been inhabitants of
the facilities after July 1st, 2010, already
discharged and to have been residents for a
minimum of 14 days. This was to ensure
that records were complete for a resident’s
entire stay, the patient had sufficient data
for use, and that the chart was still at the
site for data collection.
At conclusion of the study there
were a total of 35 residents studied. The
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most common diagnoses are listed in table
1 and patient characteristics are listed in
tables 2 and 3.

Table 3
Frequency
(%)
27 (77.1%)
19 (54.3%)
18 (51.4%)
15 (42.9%)
12 (34.3%)
11 (31.4%)
10 (28.5%)
9 (25.7%)
8 (22.9%)

Diagnosis
Hypertension
Hyperlipidemia
Depression
GERD
Diabetes
Anemia
COPD, Hypothyroid
Pneumonia
CHF/Constipation/Insomnia

Characteristic
Male
White
Married
Facility 1
Medicaid

Characteristic
Age (years)1
Duration of stay
(days)1
Weight change
(pounds)1
Diagnoses2
Maximum meds
used at once2
Beers violations (per
resident)2

Table 2
Number (%)
17 (48.6%)
22 (62.9%)
12 (34.3%)
15 (42.9%)
15 (42.9%)
Table 3
Average
74 (40-95)
41 (14-362)
-5.6 (-52-35.7)
11.97±4.1
9.26±4.3
0.46±0.76
1

median (range)
2
mean±SD
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Data Collected
The data collection sheet included
information in regards to gender, ethnicity,
duration of stay, age, marital status,
insurance coverage, admission and
discharge locations, emergency department
(ED) or hospital visit, diagnoses, weight
changes, falls, injuries, catheters and
tubing, behavioral problems, indications for
antibiotic use, pain control, and medication
use for each resident. Several students
volunteered to assist with data collection
from resident charts assisting the primary
researchers, and several hours were
dedicated to reviewing each chart to collect
all available data.
Statistical Analysis
Statistical analysis was performed by
use of SPSS with x2, Fisher’s exact test and
T-tests used for analysis. Significance was
determined to be at P=0.05.

Results
The facilities in the study had a
protocol in place for use of antibiotics
adopted from Loeb et al. Resident charts
were scanned to find indications for
antibiotic use. 15 residents (42.9%)
consumed 24 courses of antibiotics, 19
(79.2%) of which fit the criteria listed in the
protocols. There was no analysis of
association to end points at this time.
Documented diagnoses of
depression were present in 51.4% of
patients while an even more residents
(65.7%) were taking antidepressants, which
do have multiple uses. When analysis of this
data was preformed however, there was no
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noted correlation to gender, age, ethnicity,
Medicaid status, duration of stay, weight
change, and occurrence of falls, violations
to Beers criteria or ACB score.
Anticholinergics showed no
significant correlation to ethnicity, Medicaid
status, duration of stay, weight loss, need
for ED visit, gender, occurrence of falls or
number of diagnoses the resident had,
however there was an inverse relationship
to age that was tending toward significance
but had not quite attained it (r = -0.323, p =
0.058). In relation to that, Beers criteria
violations were studied, but only in patients
65 years old or older limiting the number of
residents to 26 instead of 35. That data
displayed no significant correlation to
gender, ethnicity, Medicaid status, duration
of stay, weight change, and occurrence of
falls, number of diagnoses or ACB score.

Discussion
Compliance with the Loeb protocol
was improved compared to earlier studies
that initially supported the use of protocols,
but could still use improvement as there is
not complete compliance. There is a
potential that analysis can be done to
determine if there was an influence on end
points in a future study as this study just
analyzed compliance to protocol.
Increased recognition or overdiagnosis and alternate use could account
for the increased rate of use of
antidepressants and could also influence
findings, accounting for the lack of any
significant correlations. Other potential
causes include appropriate treatment
April 2012

evening results or an inappropriate
selection of endpoints for correlation.
The suspected cause of the inverse
relationship between ACB score and patient
age is the increased caution used in
prescribing for the geriatric population
because of Beers criteria which is well
followed, as noted by only 2 patients (7.7%)
having more than one violation and the
average number of violations being 0.5.
There are some limitations to this
study though. The small sample size limits
the power of the study, but a larger sample
could strengthen results and would be
more feasible with electronic records
instead of paper charts. Another limitation
is that the multiple uses for antidepressants
may cause confusion in that part of the
study and was not taken into account. To
clarify the use of antidepressants, a
psychiatric evaluation for all residents
would need to be implemented on a regular
basis to ensure appropriate treatment of
any conditions such as depression and
dementia. With the lack of results noted in
this study, there is little reason to endorse a
larger study unless different endpoints are
selected.
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